Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.

Laboratory-based HIV tests for recent infection (TRIs), which primarily measure a specific serological biomarker(s) that distinguishes recent from long-term HIV infection, have facilitated the estimation of population-based incidence. Dried blood spots (DBS) on filter paper are an attractive sample...

Full description

Bibliographic Details
Main Authors: Kelly A Curtis, Krystin M Ambrose, M Susan Kennedy, S Michele Owen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4169399?pdf=render
id doaj-f838f511d27d4ef2ac699692814cb61c
record_format Article
spelling doaj-f838f511d27d4ef2ac699692814cb61c2020-11-24T21:58:27ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10715310.1371/journal.pone.0107153Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.Kelly A CurtisKrystin M AmbroseM Susan KennedyS Michele OwenLaboratory-based HIV tests for recent infection (TRIs), which primarily measure a specific serological biomarker(s) that distinguishes recent from long-term HIV infection, have facilitated the estimation of population-based incidence. Dried blood spots (DBS) on filter paper are an attractive sample source for HIV surveillance, given the simplified and cost-effective methods of specimen collection, storage, and shipment. Here, we evaluated the use of DBS in conjunction with an in-house multiplex TRI, the HIV-1-specific Bio-Plex assay, which measures direct antibody binding and avidity to multiple HIV-1 analytes. The assay performance was comparable between matched plasma and DBS samples from HIV-1 infected individuals obtained from diverse sources. The coefficients of variation, comparing the median antibody reactivity for each analyte between plasma and DBS, ranged from 2.78% to 9.40% and the correlation coefficients between the two sample types ranged from 0.89 to 0.97, depending on the analyte. The correlation in antibody reactivity between laboratory and site-prepared DBS for each analyte ranged from 0.87 to 0.98 and from 0.90 to 0.97 between site-prepared DBS and plasma. The correlation in assay measures between plasma and DBS indicate that the sample types can be used interchangeably with the Bio-Plex format, without negatively impacting the misclassification rate of the assay.http://europepmc.org/articles/PMC4169399?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Kelly A Curtis
Krystin M Ambrose
M Susan Kennedy
S Michele Owen
spellingShingle Kelly A Curtis
Krystin M Ambrose
M Susan Kennedy
S Michele Owen
Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
PLoS ONE
author_facet Kelly A Curtis
Krystin M Ambrose
M Susan Kennedy
S Michele Owen
author_sort Kelly A Curtis
title Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
title_short Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
title_full Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
title_fullStr Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
title_full_unstemmed Evaluation of dried blood spots with a multiplex assay for measuring recent HIV-1 infection.
title_sort evaluation of dried blood spots with a multiplex assay for measuring recent hiv-1 infection.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2014-01-01
description Laboratory-based HIV tests for recent infection (TRIs), which primarily measure a specific serological biomarker(s) that distinguishes recent from long-term HIV infection, have facilitated the estimation of population-based incidence. Dried blood spots (DBS) on filter paper are an attractive sample source for HIV surveillance, given the simplified and cost-effective methods of specimen collection, storage, and shipment. Here, we evaluated the use of DBS in conjunction with an in-house multiplex TRI, the HIV-1-specific Bio-Plex assay, which measures direct antibody binding and avidity to multiple HIV-1 analytes. The assay performance was comparable between matched plasma and DBS samples from HIV-1 infected individuals obtained from diverse sources. The coefficients of variation, comparing the median antibody reactivity for each analyte between plasma and DBS, ranged from 2.78% to 9.40% and the correlation coefficients between the two sample types ranged from 0.89 to 0.97, depending on the analyte. The correlation in antibody reactivity between laboratory and site-prepared DBS for each analyte ranged from 0.87 to 0.98 and from 0.90 to 0.97 between site-prepared DBS and plasma. The correlation in assay measures between plasma and DBS indicate that the sample types can be used interchangeably with the Bio-Plex format, without negatively impacting the misclassification rate of the assay.
url http://europepmc.org/articles/PMC4169399?pdf=render
work_keys_str_mv AT kellyacurtis evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection
AT krystinmambrose evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection
AT msusankennedy evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection
AT smicheleowen evaluationofdriedbloodspotswithamultiplexassayformeasuringrecenthiv1infection
_version_ 1725851941459722240